NCT04940429

Brief Summary

Obesity is a condition of chronic low-grade inflammation, thought to be secondary to adipose tissue secretion of cytokines including interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF- α) which effect multiple pathways and lead to an increase in C-reactive protein (CRP), a sensitive marker of systemic inflammation. Chronic inflammation is thought to be a major risk factor for the development of metabolic syndrome, diabetes, cardiovascular disease and cancer. Inflammatory cytokines have also been shown to directly and indirectly interact with the central nervous system influencing behavior and neural activity. Obesity is an independent risk factor for reduced cognitive function including poor attention, executive function and memory. Demonstrating improvement in dynamic visual processing following bariatric surgery could expand our understanding of the impact of obesity on central nervous system (CNS) function.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 27, 2018

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

June 17, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 17, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 25, 2021

Completed
Last Updated

June 25, 2021

Status Verified

June 1, 2021

Enrollment Period

2.6 years

First QC Date

June 17, 2021

Last Update Submit

June 17, 2021

Conditions

Keywords

Oculometrics

Outcome Measures

Primary Outcomes (1)

  • Change in Nfit score

    Composite oculometric testing score on Neurofit

    Baseline to 1 year post operatively

Study Arms (2)

Roux n Y Gastric Bypass (RYGB)

Participants in this arm will include patients who will be having a RYGB after their assessment by their bariatric surgeon. After reviewing and signing the consent form, participants will perform the paper-based standard psychometric tests (number connection test A and B, line tracing test, and digital subtraction test, and serial dotting test, which take about 20 minutes) at their preoperative visit. After completion of paper-based standard psychometric tests, participants will then perform the computer application test which takes about 5 minutes at their preoperative visit. These will also be performed at their post operative visits 2 weeks, 3, 6 and 12 months.

Device: NeurofitDiagnostic Test: Psychometric hepatic encephalopathy score

Sleeve gastrectomy (SG)

Participants in this arm will include patients who will be having a SG after their assessment by their bariatric surgeon. After reviewing and signing the consent form, participants will perform the paper-based standard psychometric tests (number connection test A and B, line tracing test, and digital subtraction test, and serial dotting test, which take about 20 minutes) at their preoperative visit. After completion of paper-based standard psychometric tests, participants will then perform the computer application test which takes about 5 minutes at their preoperative visit: These will also be performed at their post operative visits 2 weeks, 3, 6 and 12 months.

Device: NeurofitDiagnostic Test: Psychometric hepatic encephalopathy score

Interventions

NeurofitDEVICE

This involves sitting on a chair with a head and chin rest to maintain stability. Patients will then follow a moving object on the computer screen with their eyes which allows estimation of individual oculometrics along with a composite score. No physical contact or placement of invasive devices will be performed.

Roux n Y Gastric Bypass (RYGB)Sleeve gastrectomy (SG)

During the number connection tests, the participant is asked to join dots between numbers or numbers and letters in a timed fashion and the number of seconds required is the outcome. In the line tracing test, participants are required to trace a line between two parallel lines and the time required is noted. Also, the number of times the subject strays outside the line (line tracing test error) is captured. In the digit symbol test, participants are required to pair numbers with special symbols. An individual's score reflects the number of correct pairs achieved in 120 seconds. In the serial dotting test, participants are asked to dot the center of a group of blank circles and the time required to complete the test is the outcome. Psychometric tests will be completed at their post-operative visits.

Roux n Y Gastric Bypass (RYGB)Sleeve gastrectomy (SG)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Obese patients being considered for weight loss surgery by their bariatric surgeons.

You may qualify if:

  • Patients who are overweight or obese (Body Mass Index over 25 and 30, respectively)

You may not qualify if:

  • Individuals \<18 years
  • Patients with history of cognitive brain disease including traumatic brain injury, dementia, Parkinson's disease
  • Individuals with uncontrolled neuropsychiatric illnesses or overt hepatic encephalopathy
  • Ongoing alcohol or illicit substance use
  • patients with cirrhosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University School of Medicine

Redwood City, California, 94063, United States

Location

MeSH Terms

Conditions

Obesity, Morbid

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

June 17, 2021

First Posted

June 25, 2021

Study Start

November 27, 2018

Primary Completion

June 17, 2021

Study Completion

June 17, 2021

Last Updated

June 25, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations